Citation Tools

other Versions

PDF

Extended report
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

Download to a citation manager

Cite this article as:
Khanna D, Denton CP, Lin CJ, et al
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)